Stay updated on Pembrolizumab for Leptomeningeal Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.

Latest updates to the Pembrolizumab for Leptomeningeal Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check31 days agoChange DetectedThe revision label in the UI was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedMinor site-wide update to Revision: v3.4.2 and removal of the government funding status notice; no changes to trial content, enrollment, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check67 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, with guidance to check cc.nih.gov and opm.gov for updates. The page revision version was updated from 3.4.0 to 3.4.1.SummaryDifference0.5%

- Check74 days agoChange DetectedThe changes are minor UI and metadata updates, including the addition of a Show glossary option and revision/version labels, as well as small wording/capitalization adjustments to several fields; these do not alter core trial content or patient-facing information. There are no changes to the study details, eligibility criteria, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check88 days agoChange DetectedThe page now shows a revision updated from v3.3.3 to v3.3.4, with the previous revision label removed and the new revision added. This is a metadata update and does not alter study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Leptomeningeal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.